Showing 341 - 360 results of 100,433 for search '(( 5 mg decrease ) OR ( 5 ((((non decrease) OR (point decrease))) OR (a decrease)) ))', query time: 1.54s Refine Results
  1. 341
  2. 342
  3. 343
  4. 344

    U87MG glioma cells transduced with gal-3 shRNA demonstrate decreased tumor size and growth. by Rafael Yamashita Ikemori (698128)

    Published 2014
    “…<b><i>C</i></b>. The inoculation of U87MG gal-3 shRNA cells in the flank of nuce mice (n = 5) demonstrated a decrease in tumor size and growth compared to the U87MG scramble shRNA (n = 6). …”
  5. 345

    Cumulative effects and geographic distribution of mCHG-decreasing alleles. by Eriko Sasaki (501178)

    Published 2022
    “…The insert shows the six observed genotypes with three mCHG-decreasing and the <i>NRPE1’</i> non-reference allele. …”
  6. 346
  7. 347
  8. 348
  9. 349

    Preconditioning anti-VEGF antibody decreased IR-induced pulmonary edema and microvascular hyper-permeability. by Chou-Chin Lan (2938674)

    Published 2016
    “…The Kf2 was significantly increased in the IR group and decreased in the B5-IR group (5 mg/kg) (p<0.05). There was a significant difference from the * CTRL (<i>p</i><0.05) and <sup>#</sup>IR (<i>p</i><0.05) groups. …”
  10. 350

    Preconditioning anti-VEGF antibody decreased total protein concentration and pro-inflammatory cytokines in BALF. by Chou-Chin Lan (2938674)

    Published 2016
    “…Preconditioning anti-VEGF antibody (5 mg/kg) decreased IR-induced total protein concentration and TNF-α in BALF (both <i>p</i><0.05). …”
  11. 351
  12. 352
  13. 353
  14. 354
  15. 355
  16. 356

    Effects of conivaptan on brain water content (BWC), blood-brain-barrier (BBB) disruption, plasma and urine sodium and osmolality. by Emil Zeynalov (596088)

    Published 2015
    “…Following MCAO, Evans Blue (EB) extravasation index (I/C) was increased in vehicle treated mice, and reduced in conivaptan treated mice, naïve, n = 5, vehicle, n = 8, Conivaptan 0.2 mg, n = 8. (C, D) Conivaptan treatment of 0.2 mg resulted in an elevation of plasma sodium and osmolality, and decreased urine sodium and osmolality due to aquaresis. …”
  17. 357
  18. 358
  19. 359
  20. 360